Changes in the therapy of operable breast cancer. Treatment of small breast cancer and preinvasive stages
Thomsen, K.
Fortschritte der Medizin 105(22): 425-428
1987
ISSN/ISBN: 0015-8178 PMID: 3653826 Document Number: 287665
Document emailed within 1 workday
Related Documents
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104Noguchi, M.; Yagasaki, R.; Kawahara, F.; Minami, M.; Tsuyama, H.; Earashi, M.; Kinoshita, K.; Taniya, T.; Miwa, K.; Nishijima, H.; Takanaka, T.; Kawashima, H.; Takashima, C.; Kanno, M.; Nakamura, S.; Mizukami, Y.; Nonomura, A.; Michigishi, T.; Yokoyama, K. 1997: Breast conserving treatment versus modified radical mastectomy in Japanese patients with operable breast cancer International Surgery 82(3): 289-294
Messina, G.; Lissoni, P.; Brivio, F.; Rovelli, F.; Fumagalli, L.; Bartolacelli, E.; Mazza, U.; Colombo, E.; Bertoglio, A. 2008: A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviour In Vivo 22(6): 845-848
Hudis, C.A.; Norton, L. 1996: Adjuvant drug therapy for operable breast cancer Seminars in Oncology 23(4): 475-493
Fentiman, I. 1988: The treatment of operable breast cancer Practitioner 232(1456): 1086-1090
Kubista, E. 1990: Ablative versus conservative therapy of operable breast cancer Zentralblatt für Gynakologie 112(18): 1143-1150
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
O'Brien, P.H. 1976: Adjuvant treatment in operable breast cancer Journal of the South Carolina Medical Association 72(5): 173-174
Fentiman, I.S. 1985: Surgical options for the treatment of operable breast cancer Practitioner 229(1401): 241-244
Rossi, A.; Valagussa, P.; Bonadonna, G. 1977: Surgery and adjuvant chemotherapy in the treatment of operable breast cancer Progress in Clinical and Biological Research 12: 391-404
Conti, F.; Sergi, D.; Foggi, P.; Abbate, M.I.; Lopez, M. 2007: New combination chemotherapy regimens in the primary treatment of operable breast cancer La Clinica Terapeutica 158(1): 55-75
Fodor, J.; Polgár, C.; Németh, G. 2000: Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies Orvosi Hetilap 141(28): 1551-1555
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Mustacchi, G.; Milani, S.; Pluchinotta, A.; De Matteis, A.; Rubagotti, A.; Perrota, A. 1994: Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly Anticancer Research 14(5b): 2197-2200
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Ohsumi, S.; Takashima, S.; Saeki, T.; Aogi, K. 2002: Breast-conserving therapy consisting of wide excision, axillary dissection, and radiotherapy for early-stage breast cancer: the experience of the National Shikoku Cancer Center Biomedicine and PharmacoTherapy 56(Suppl): 196s-200s
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Smallwood, J.A.; Kye, D.A.; Taylor, I. 1986: Mastalgia; is this commonly associated with operable breast cancer? Annals of the Royal College of Surgeons of England 68(5): 262-263